RNS Number:0632C
Hikma Pharmaceuticals Plc
26 April 2006




                            Annual Information Update

LONDON, 26 April 2006. In accordance with Prospectus Rule 5.2, Hikma
Pharmaceuticals PLC ("Hikma" or "the Company")(LSE: HIK) sets out below a
summary of the information which has been published or made available to the
public over the previous 12 months. The information referred to in this Update
was up to date at the time the information was published, but some information
may now be out of date.

Stock Exchange announcements

Announcements made by the Company via RNS, a Regulatory Information Service, may
be viewed and downloaded from the London Stock Exchange website 
(www.londonstockexchange.com/marketnews) or from the press releases page on the
Company's website at (http://investors.hikma.com/hikma/regulatorynews.jsp). The
Stock Exchange announcements made during the defined period are:

Date of announcement     Headline of announcement

25 Apr 2006              Hikma to list Global Depository Receipts on DIFX
21 Apr 2006              Notification of Transaction
19 Apr 2006              Hikma acquires JPI
03 Apr 2006              Block listing
29 Mar 2006              Hikma Preliminary Results
25 Jan 2006              Hikma Announces FDA Approval
23 Jan 2006              Trading Statement
05 Dec 2005              Director/PDMR Shareholding
30 Nov 2005              Over allotment option
28 Nov 2005              Renewal of Contract
04 Nov 2005              Director/PDMR Shareholding
02 Nov 2005              Publication of Prospectus
01 Nov 2005              Stabilisation Notice
01 Nov 2005              Pricing Announcement
17 Oct 2005              Hikma Pharmaceutials announces intention to float

Documents filed with the Financial Services Authority

The company has filed the following documents with the Financial Services
Authority ("FSA") over the previous 12 months. These documents are or will be
available to be viewed via the FSA's Document Viewing Facility or at the
Company's registered office.

Date filed with the FSA           Document filed with the FSA

26 Apr 2006                       Annual report and accounts
26 Apr 2006                       Notice of Annual General Meeting
01 Nov 2005                       Prospectus

Documents filed with Companies House

The Company has made the following filings with Companies House. Copies of these
documents may be obtained from Companies House, Crown Way, Maindy, Cardiff CF14
3UZ or, if you are a registered user, they may be viewed and downloaded using
Companies House Direct at www.direct.companieshouse.gov.uk. The Companies House
filings made during the defined period are:

Date filed with            Document filed with Companies House
Companies House

26 Apr 2006                2005 Annual report and accounts
26 Apr 2006                Notice of Annual General Meeting
13 Feb 2006                Form 123 - Notice of increase in share capital
13 Feb 2006                Form 122 - Notice of sub-division
13 Feb 2006                Authorisation of allotment of securities
17 Jan 2006                Form 288a - Director appointed
29 Nov 2005                Form 288a - Director appointed
29 Nov 2005                Form 288a - Director appointed
29 Nov 2005                Form 288a - Director appointed
07 Nov 2005                Adoption of Memorandum of Association and Articles of
                           Association
28 Oct 2005                Company name change
23 Sep 2005                Approval of change of rights of all shares
23 Sep 2005                Memorandum of Association and Articles of
                           Association
19 Sep 2005                Company name change
22 Sep 2005                Form 288a - Director appointed
22 Sep 2005                Form 288a - Secretary appointed
22 Sep 2005                Form 288a - Director appointed
22 Sep 2005                Form 288a - Director resigned; Secretary resigned
22 Sep 2005                Form 288a - Director resigned
22 Sep 2005                Form 225 - Change of accounting reference date
16 Sep 2005                Authorisation to commence business and borrow
16 Sep 2005                Form 117 - Application to commence business
08 Sep 2005                Incorporation documents

In addition, the Company filed Forms 88(2) - Return of Allotment of Shares with
Companies House. These were posted on the Companies House Direct website on 13
February 2006 and 22 September.

Henry Knowles
Company Secretary
27 April 2006
                                    - ENDS -

Enquiries:


Hikma Pharmaceuticals plc                             +44 20 7479 4870
Henry Knowles, Company Secretary                      +44 20 7479 4893
Susan Ringdal, Investor Relations Director
Brunswick Group LLP                                   +44 20 7404 5959
Jon Coles / Wendel Verbeek / Justine McIlroy / Alex
Tweed

Notes to Editors

About Hikma
Hikma Pharmaceuticals PLC is a multinational pharmaceutical group focused on
developing, manufacturing and marketing a broad range of both branded and
non-branded generic and in-licensed pharmaceutical products. Hikma's operations
are conducted through three businesses: Generic, Branded and Injectable
Pharmaceuticals. Hikma's operations are based principally in the United States,
the Middle East and North Africa ("MENA") region and Europe. In 2005, the Group
had revenue of $262 million and profit attributable to shareholders of $44
million. At 31 December 2005, the Group had over 1,800 employees. For news and
other information, please visit www.hikma.com.




                      This information is provided by RNS
            The company news service from the London Stock Exchange


END

MSCDQLFLQZBBBBK
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Hikma Pharmaceuticals Charts.
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Hikma Pharmaceuticals Charts.